标题
Anakinra Therapy for Non-cancer Inflammatory Diseases
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-11-06
DOI
10.3389/fphar.2018.01157
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: A retrospective cases series
- (2018) Isabelle Kone-Paut et al. AUTOIMMUNITY REVIEWS
- Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature
- (2018) Hafize Emine Sönmez et al. CLINICAL RHEUMATOLOGY
- Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions
- (2018) Lawrence J. Hirsch et al. EPILEPSIA
- Interleukin-1 blockade in cardiovascular diseases: a clinical update
- (2018) Leo F Buckley et al. EUROPEAN HEART JOURNAL
- Prevalence of Takayasu arteritis in young women with acute ischemic heart disease
- (2018) Giulio Cavalli et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Severe Late-Onset Kawasaki Disease Successfully Treated With Anakinra
- (2018) Gauthier Blonz et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Interleukin-37 Treatment of Mice with Metabolic Syndrome Improves Insulin Sensitivity and Reduces Pro-inflammatory Cytokine Production in Adipose Tissue
- (2018) Dov B Ballak et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Systemic autoinflammation with intractable epilepsy managed with interleukin-1 blockade
- (2018) Allen D. DeSena et al. Journal of Neuroinflammation
- Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes
- (2018) Brendan M. Everett et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
- (2018) Paul M Ridker et al. LANCET
- Kawasaki Disease Shock Syndrome; A Unique and Severe Subtype of Kawasaki Disease
- (2018) Luisa Berenise Gamez-Gonzalez et al. PEDIATRICS INTERNATIONAL
- β Cell-Specific Deletion of the IL-1 Receptor Antagonist Impairs β Cell Proliferation and Insulin Secretion
- (2018) Marianne Böni-Schnetzler et al. Cell Reports
- Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim–Chester Disease
- (2018) Alessandro Tomelleri et al. Frontiers in Immunology
- Myocarditis: An Interleukin-1-Mediated Disease?
- (2018) Giacomo De Luca et al. Frontiers in Immunology
- The fibrogenic chemokine CCL18 is associated with disease severity in Erdheim-Chester disease
- (2018) Greta Pacini et al. OncoImmunology
- Treatment of Dilated Cardiomyopathy With Interleukin-1 Inhibition
- (2018) Giacomo De Luca et al. ANNALS OF INTERNAL MEDICINE
- Suppression of inflammation and acquired immunity by IL-37
- (2017) Giulio Cavalli et al. IMMUNOLOGICAL REVIEWS
- Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition
- (2017) Scott W. Canna et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Adult leukoencephalopathies with prominent infratentorial involvement can be caused by Erdheim–Chester disease
- (2017) Luisa Chiapparini et al. JOURNAL OF NEUROLOGY
- Elevated Expression of the NLRP3 Inflammasome and Its Correlation with Disease Activity in Adult-onset Still Disease
- (2017) Chia-Wei Hsieh et al. JOURNAL OF RHEUMATOLOGY
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin 37 reverses the metabolic cost of inflammation, increases oxidative respiration, and improves exercise tolerance
- (2017) Giulio Cavalli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation
- (2017) Giulio Cavalli et al. RHEUMATOLOGY
- Adult onset Still’s disease—The evidence that anti-interleukin-1 treatment is effective and well-tolerated (a comprehensive literature review)
- (2017) Guido Junge et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Advances in potential targeted therapies for Erdheim-Chester disease
- (2017) Giulio Cavalli et al. Expert Opinion on Orphan Drugs
- Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still’s Disease: A Multicentre Retrospective Observational Study
- (2017) Serena Colafrancesco et al. Frontiers in Pharmacology
- IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus
- (2017) Concepción Peiró et al. Frontiers in Pharmacology
- IL-1 Inhibition May Have an Important Role in Treating Refractory Kawasaki Disease
- (2017) Perrine Dusser et al. Frontiers in Pharmacology
- Peri- and Postoperative Treatment with the Interleukin-1 Receptor Antagonist Anakinra Is Safe in Patients Undergoing Renal Transplantation: Case Series and Review of the Literature
- (2017) Catharina M. Mulders-Manders et al. Frontiers in Pharmacology
- Interleukin-1 Receptor Blockade Rescues Myocarditis-Associated End-Stage Heart Failure
- (2017) Giulio Cavalli et al. Frontiers in Immunology
- Tocilizumab in patients with multisystem Erdheim–Chester disease
- (2017) Alvise Berti et al. OncoImmunology
- Biologics for rheumatoid arthritis: an overview of Cochrane reviews
- (2017) Jasvinder A. Singh et al. Sao Paulo Medical Journal
- Superior efficacy and tolerance of reduced doses of vemurafenib plus anakinra in Erdheim-Chester disease: Towards the paradigm of combined targeting and immune therapies
- (2016) Fréderic Franconieri et al. ACTA ONCOLOGICA
- Febrile infection-related epilepsy syndrome treated with anakinra
- (2016) Daniel L. Kenney-Jung et al. ANNALS OF NEUROLOGY
- Anakinra as efficacious therapy for 2 cases of intracranial Erdheim-Chester disease
- (2016) E. L. Diamond et al. BLOOD
- Treating Life-Threatening Myocarditis by Blocking Interleukin-1*
- (2016) Giulio Cavalli et al. CRITICAL CARE MEDICINE
- Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome
- (2016) Bita Shakoory et al. CRITICAL CARE MEDICINE
- Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence
- (2016) Antonio Brucato et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Interleukin-1 Blockade in Acute Decompensated Heart Failure
- (2016) Benjamin W. Van Tassell et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Erdheim–Chester Disease With Multiorgan Involvement, Following Polycythemia Vera
- (2016) Alessandra Iurlo et al. MEDICINE
- Autoimmune vitiligo is associated with gain-of-function by a transcriptional regulator that elevates expression ofHLA-A*02:01in vivo
- (2016) Masahiro Hayashi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo
- (2016) Giulio Cavalli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation
- (2016) Giulio Cavalli et al. RHEUMATOLOGY
- Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes
- (2016) Torbjörn Kullenberg et al. RHEUMATOLOGY
- Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa
- (2016) Vassiliki Tzanetakou et al. JAMA Dermatology
- A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study
- (2016) Antonio Vitale et al. Frontiers in Pharmacology
- Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim–Chester disease
- (2016) Elisabetta Ferrero et al. OncoImmunology
- Treating Pulmonary Silicosis by Blocking Interleukin 1
- (2015) Giulio Cavalli et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pathogenesis of Macrophage Activation Syndrome and Potential for Cytokine- Directed Therapies
- (2015) Grant S. Schulert et al. Annual Review of Medicine
- Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease
- (2015) Luca Cantarini et al. AUTOIMMUNITY REVIEWS
- Giant cell arteritis restricted to the limb arteries: An overlooked clinical entity
- (2015) Alvise Berti et al. AUTOIMMUNITY REVIEWS
- Erdheim-Chester disease
- (2015) Corrado Campochiaro et al. European Journal of Internal Medicine
- Myeloid lineage–restricted somatic mosaicism of NLRP3 mutations in patients with variant Schnitzler syndrome
- (2015) Heleen D. de Koning et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Study design and population pharmacokinetic analysis of a phase II dose-ranging study of interleukin-1 receptor antagonist
- (2015) Kayode Ogungbenro et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies
- (2015) Giulio Cavalli et al. RHEUMATOLOGY
- Efficacy and safety of biological agents in adult-onset Still’s disease
- (2015) G Cavalli et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- IL-1β, IL-6 and IL1Ra levels in temporal lobe epilepsy
- (2015) Irem Fatma Uludag et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Interleukin-18 mediates interleukin-1-induced cardiac dysfunction
- (2014) Stefano Toldo et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease
- (2014) Maria Giulia Cangi et al. ANNALS OF THE RHEUMATIC DISEASES
- Adult-onset Still's disease
- (2014) Mathieu Gerfaud-Valentin et al. AUTOIMMUNITY REVIEWS
- Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease
- (2014) E. L. Diamond et al. BLOOD
- The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study
- (2014) A. C. Morton et al. EUROPEAN HEART JOURNAL
- Idiopathic recurrent pericarditis as an immune-mediated disease: current insights into pathogenesis and emerging treatment options
- (2014) Massimo Imazio Expert Review of Clinical Immunology
- Cardiac magnetic resonance in myocarditis from adult onset Still's disease successfully treated with anakinra
- (2014) Andrew D. Choi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Recombinant Human Interleukin-1 Receptor Antagonist in Severe Traumatic Brain Injury: A Phase II Randomized Control Trial
- (2014) Adel Helmy et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Early efficacy trial of anakinra in corticosteroid-resistant autoimmune inner ear disease
- (2014) Andrea Vambutas et al. JOURNAL OF CLINICAL INVESTIGATION
- The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial
- (2014) Navneet Singh et al. Journal of Neuroinflammation
- Therapeutic Role of Anakinra, an Interleukin-1 Receptor Antagonist, in the Management of Secondary Hemophagocytic Lymphohistiocytosis/Sepsis/Multiple Organ Dysfunction/Macrophage Activating Syndrome in Critically Ill Children*
- (2014) Surender Rajasekaran et al. Pediatric Critical Care Medicine
- Oncogene-Induced Senescence as a New Mechanism of Disease: The Paradigm of Erdheim–Chester Disease
- (2014) Giulio Cavalli et al. Frontiers in Immunology
- Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) Pilot Study]
- (2013) Antonio Abbate et al. AMERICAN JOURNAL OF CARDIOLOGY
- Diagnosing Erdheim–Chester disease
- (2013) Giulio Cavalli et al. ANNALS OF THE RHEUMATIC DISEASES
- Results from systematic screening for cardiovascular risk in outpatients with rheumatoid arthritis in accordance with the EULAR recommendations
- (2013) Jette Primdahl et al. ANNALS OF THE RHEUMATIC DISEASES
- The multifaceted clinical presentations and manifestations of Erdheim–Chester disease: comprehensive review of the literature and of 10 new cases
- (2013) Giulio Cavalli et al. ANNALS OF THE RHEUMATIC DISEASES
- Autoinflammatory Skin Disorders in Inflammatory Bowel Diseases, Pyoderma Gangrenosum and Sweet’s Syndrome: a Comprehensive Review and Disease Classification Criteria
- (2013) Angelo V. Marzano et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Anakinra treatment in drug-resistant Behcet’s disease: a case series
- (2013) Luca Cantarini et al. CLINICAL RHEUMATOLOGY
- Double-Blind, Randomized Study Evaluating the Glycemic and Anti-inflammatory Effects of Subcutaneous LY2189102, a Neutralizing IL-1 Antibody, in Patients With Type 2 Diabetes
- (2013) J. Sloan-Lancaster et al. DIABETES CARE
- Macrophage Activation Syndrome Secondary to Human Monocytic Ehrlichiosis
- (2013) Nilay Kumar et al. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
- Erdheim–Chester disease with cardiac involvement successfully treated with anakinra
- (2013) Ammar M. Killu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Interleukin-1 blockade in refractory giant cell arteritis
- (2013) Kim-Heang Ly et al. JOINT BONE SPINE
- Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
- (2013) Antoinette Moran et al. LANCET
- Cytokine profiles in children with primary Epstein-Barr virus infection
- (2013) Taizo Wada et al. PEDIATRIC BLOOD & CANCER
- Interleukin-6, interleukin-1 beta and interleukin-1 receptor antagonist levels in epileptic seizures
- (2013) Irem Fatma Uludag et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens
- (2013) Jasmin B Kuemmerle-Deschner et al. ARTHRITIS RESEARCH & THERAPY
- Neutrophilic Urticaria With Systemic Inflammation
- (2013) Hrishikesh Belani et al. JAMA Dermatology
- Successful Treatment of Severe Hidradenitis Suppurativa With Anakinra
- (2013) Kian Zarchi et al. JAMA Dermatology
- Topical Interleukin 1 Receptor Antagonist for Treatment of Dry Eye Disease
- (2013) Francisco Amparo et al. JAMA Ophthalmology
- Effectiveness of First-Line Treatment With Recombinant Interleukin-1 Receptor Antagonist in Steroid-Naive Patients With New-Onset Systemic Juvenile Idiopathic Arthritis: Results of a Prospective Cohort Study
- (2013) Sebastiaan J. Vastert et al. Arthritis & Rheumatology
- Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease
- (2013) Loris R. Lopetuso et al. Frontiers in Immunology
- New Insights in the Immunobiology of IL-1 Family Members
- (2013) Frank L. van de Veerdonk et al. Frontiers in Immunology
- Efficacy of anti-IL-1 treatment in Majeed syndrome
- (2012) Troels Herlin et al. ANNALS OF THE RHEUMATIC DISEASES
- A pilot study of IL-1 inhibition in acute calcific periarthritis of the shoulder
- (2012) Pascal Zufferey et al. ANNALS OF THE RHEUMATIC DISEASES
- Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome
- (2012) Heleen D de Koning et al. ANNALS OF THE RHEUMATIC DISEASES
- Anakinra treatment of SAPHO syndrome: short-term results of an open study
- (2012) Daniel Wendling et al. ANNALS OF THE RHEUMATIC DISEASES
- A child with severe relapsing Kawasaki disease rescued by IL-1 receptor blockade and extracorporeal membrane oxygenation
- (2012) Sophie Cohen et al. ANNALS OF THE RHEUMATIC DISEASES
- Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: A cohort study to determine three- and five-year outcomes
- (2012) Cailin H. Sibley et al. ARTHRITIS AND RHEUMATISM
- Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): State of the art and future perspectives
- (2012) Luca Cantarini et al. AUTOIMMUNITY REVIEWS
- Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes
- (2012) C. Cavelti-Weder et al. DIABETES CARE
- Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial
- (2012) A. Rissanen et al. DIABETES OBESITY & METABOLISM
- Interleukin-1β blockade improves cardiac remodelling after myocardial infarction without interrupting the inflammasome in the mouse
- (2012) Stefano Toldo et al. EXPERIMENTAL PHYSIOLOGY
- A rare case of pericarditis, complication of infliximab treatment for Crohn's disease
- (2012) Joe Devasahayam et al. Journal of Crohns & Colitis
- Silicosis
- (2012) Chi Chiu Leung et al. LANCET
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
- (2012) Charles A. Dinarello et al. NATURE REVIEWS DRUG DISCOVERY
- Chronic Recurrent Multifocal Osteomyelitis and Deficiency of Interleukin-1–receptor Antagonist
- (2012) Waheeb Sakran et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Clinical, Genetic, and Therapeutic Diversity in 2 Patients With Severe Mevalonate Kinase Deficiency
- (2012) A. Ruiz Gomez et al. PEDIATRICS
- Interleukin-1 Inhibition and Fatigue in Primary Sjögren's Syndrome – A Double Blind, Randomised Clinical Trial
- (2012) Katrine Brække Norheim et al. PLoS One
- Enhanced Interleukin-1 Activity Contributes to Exercise Intolerance in Patients with Systolic Heart Failure
- (2012) Benjamin W. Van Tassell et al. PLoS One
- Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behçet's disease: an open-label pilot study
- (2011) Ahmet Gül et al. ANNALS OF THE RHEUMATIC DISEASES
- Variable expression and treatment of PAPA syndrome
- (2011) M. A. Schellevis et al. ANNALS OF THE RHEUMATIC DISEASES
- Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes
- (2011) J. B. Kuemmerle-Deschner et al. ANNALS OF THE RHEUMATIC DISEASES
- On-demand anakinra treatment is effective in mevalonate kinase deficiency
- (2011) E. J. Bodar et al. ANNALS OF THE RHEUMATIC DISEASES
- Familial and Acquired Hemophagocytic Lymphohistiocytosis
- (2011) G.E. Janka Annual Review of Medicine
- Role of interleukin-1β in NLRP12-associated autoinflammatory disorders and resistance to anti-interleukin-1 therapy
- (2011) Isabelle Jéru et al. ARTHRITIS AND RHEUMATISM
- A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features
- (2011) Nicolino Ruperto et al. ARTHRITIS AND RHEUMATISM
- Blau syndrome
- (2011) Leonardo Punzi et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Gene expression profiling of peripheral blood mononuclear cells from children with active hemophagocytic lymphohistiocytosis
- (2011) J. Sumegi et al. BLOOD
- Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, phase II, dose-finding study
- (2011) Rieke Alten et al. BMC MUSCULOSKELETAL DISORDERS
- IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures
- (2011) Annamaria Vezzani et al. BRAIN BEHAVIOR AND IMMUNITY
- Hyper-IgD syndrome or mevalonate kinase deficiency
- (2011) Monique Stoffels et al. CURRENT OPINION IN RHEUMATOLOGY
- Efficacy of Anti-Interleukin-1 Receptor Antagonist Anakinra (Kineret®) in a Case of Refractory Sweet’s Syndrome
- (2011) Nicolas Kluger et al. DERMATOLOGY
- Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
- (2011) Greta Guarda et al. IMMUNITY
- Treatment with Anakinra Improves Disposition Index But Not Insulin Sensitivity in Nondiabetic Subjects with the Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study
- (2011) Edwin J. P. van Asseldonk et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- IL-1 Is Overexpressed and Aberrantly Regulated in Corticosteroid Nonresponders with Autoimmune Inner Ear Disease
- (2011) S. Pathak et al. JOURNAL OF IMMUNOLOGY
- Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)?a new autoinflammatory syndrome distinct from PAPA syndrome
- (2011) Markus Braun-Falco et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure
- (2011) K. Stankovic Stojanovic et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Cryopyrin-Associated Periodic Syndromes
- (2011) Neda Ahmadi et al. OTOLARYNGOLOGY-HEAD AND NECK SURGERY
- Partial response to anakinra in life-threatening Henoch-Schönlein purpura: case report
- (2011) Erynn M Boyer et al. Pediatric Rheumatology
- Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade
- (2011) S. Stojanov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interleukin-1 Targeting Drugs in Familial Mediterranean Fever: A Case Series and a Review of the Literature
- (2011) Ulrich Meinzer et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- NLRP3 E311K mutation in a large family with Muckle-Wells syndrome - description of a heterogeneous phenotype and response to treatment
- (2011) Jasmin B Kuemmerle-Deschner et al. ARTHRITIS RESEARCH & THERAPY
- A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee
- (2011) Stanley B Cohen et al. ARTHRITIS RESEARCH & THERAPY
- Current Status of Understanding the Pathogenesis and Management of Patients With NOMID/CINCA
- (2011) Raphaela Goldbach-Mansky Current Rheumatology Reports
- Interleukin-1 Blockade With Anakinra to Prevent Adverse Cardiac Remodeling After Acute Myocardial Infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot Study)
- (2010) Antonio Abbate et al. AMERICAN JOURNAL OF CARDIOLOGY
- IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease
- (2010) L Naumann et al. ANNALS OF THE RHEUMATIC DISEASES
- A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
- (2010) P. Quartier et al. ANNALS OF THE RHEUMATIC DISEASES
- Hidradenitis Suppurativa and Concomitant Pyoderma Gangrenosum
- (2010) Jennifer L. Hsiao et al. ARCHIVES OF DERMATOLOGY
- Engagement of fatty acids with toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis
- (2010) Leo A. B. Joosten et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of anakinra therapy in pediatric and adult patients with the autoinflammatory Muckle-Wells syndrome
- (2010) Jasmin B. Kuemmerle-Deschner et al. ARTHRITIS AND RHEUMATISM
- Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease
- (2010) A. Aouba et al. BLOOD
- Clinical experience of QuantiFERON®-TB Gold testing in patients with psoriasis treated with tumour necrosis factor blockers in Taiwan
- (2010) H-Y. Chiu et al. BRITISH JOURNAL OF DERMATOLOGY
- The Inflammasome-Mediated Caspase-1 Activation Controls Adipocyte Differentiation and Insulin Sensitivity
- (2010) Rinke Stienstra et al. Cell Metabolism
- Inflammasome and IL-1β-Mediated Disorders
- (2010) Hal M. Hoffman et al. CURRENT ALLERGY AND ASTHMA REPORTS
- Macrophage activation syndrome: advances towards understanding pathogenesis
- (2010) Alexei A Grom et al. CURRENT OPINION IN RHEUMATOLOGY
- Cytophagic histiocytic panniculitis and hemophagocytic lymphohistiocytosis: an overview
- (2010) Iris K. Aronson et al. Dermatologic Therapy
- Anakinra for Difficult-to-Treat Neutrophilic Panniculitis: IL-1 Blockade as a Promising Treatment Option for Neutrophil-Mediated Inflammatory Skin Disease
- (2010) Dan Lipsker et al. DERMATOLOGY
- The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
- (2010) I. Solovic et al. EUROPEAN RESPIRATORY JOURNAL
- Anakinra efficacy in a Caucasian patient with renal AA amyloidosis secondary to cryopyrin-associated periodic syndrome
- (2010) Tassadit Aït-Abdesselam et al. JOINT BONE SPINE
- Adult-onset Still's disease with myocarditis successfully treated with the interleukin-1 receptor antagonist anakinra
- (2010) Bernd Raffeiner et al. JOINT BONE SPINE
- Intravenous Anakinra can Achieve Experimentally Effective Concentrations in the Central Nervous System within a Therapeutic Time Window: Results of a Dose-Ranging Study
- (2010) James Galea et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Interleukin (IL)-1β, IL-1 receptor antagonist, IL-6, IL-8, IL-10, and tumor necrosis factor α gene polymorphisms in patients with febrile seizures
- (2010) I-Ching Chou et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Anti-Interleukin 1 Treatment for Patients with Familial Mediterranean Fever Resistant to Colchicine: Table 1.
- (2010) SEZA ÖZEN et al. JOURNAL OF RHEUMATOLOGY
- Rückbildung der Schwerhörigkeit bei einer Patientin mit Muckle-Wells-Syndrom unter Therapie mit Anakinra
- (2010) A. Klein et al. KLINISCHE PADIATRIE
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
- IL-37 is a fundamental inhibitor of innate immunity
- (2010) Marcel F Nold et al. NATURE IMMUNOLOGY
- Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes
- (2010) Seth L Masters et al. NATURE IMMUNOLOGY
- Neurologic manifestations of the cryopyrin-associated periodic syndrome
- (2010) J. L. Kitley et al. NEUROLOGY
- Dysregulation of P2X7 receptor-inflammasome axis in SAPHO syndrome: successful treatment with anakinra
- (2010) M. Colina et al. RHEUMATOLOGY
- Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients
- (2010) P. M. Miettunen et al. RHEUMATOLOGY
- Biologic therapy in refractory chronic non-bacterial osteomyelitis of childhood
- (2010) Despina Eleftheriou et al. RHEUMATOLOGY
- Typical and severe tumor necrosis factor receptor–associated periodic syndrome in the absence of mutations in the TNFRSF1A gene: a case series
- (2010) Luca Cantarini et al. RHEUMATOLOGY INTERNATIONAL
- Pneumonia in a patient with familial Mediterranean fever successfully treated with anakinra—case report and review
- (2010) Stefanie Hennig et al. RHEUMATOLOGY INTERNATIONAL
- Erosive osteoarthritis of the hand: clinical experience with anakinra
- (2009) L Bacconnier et al. ANNALS OF THE RHEUMATIC DISEASES
- The Inflammasomes: Guardians of the Body
- (2009) Fabio Martinon et al. Annual Review of Immunology
- Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1β receptor antagonist (anakinra): An unrecognized autoinflammatory disease?
- (2009) Paolo Picco et al. ARTHRITIS AND RHEUMATISM
- Inflammatory arthritis in caspase 1 geneâdeficient mice: Contribution of proteinase 3 to caspase 1âindependent production of bioactive interleukin-1β
- (2009) Leo A. B. Joosten et al. ARTHRITIS AND RHEUMATISM
- Intraarticular injection of anakinra in osteoarthritis of the knee: A multicenter, randomized, double-blind, placebo-controlled study
- (2009) X. Chevalier et al. ARTHRITIS AND RHEUMATISM
- Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome
- (2009) Bénédicte Neven et al. ARTHRITIS AND RHEUMATISM
- The role of interleukin-1β in febrile seizures
- (2009) James G. Heida et al. BRAIN & DEVELOPMENT
- Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra
- (2009) M. Brenner et al. BRITISH JOURNAL OF DERMATOLOGY
- Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes
- (2009) C. M. Larsen et al. DIABETES CARE
- Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure
- (2009) Nadia Announ et al. JOINT BONE SPINE
- IL-1RA Agonist (Anakinra) in the Treatment of Multifocal Castleman Disease
- (2009) Caroline Galeotti et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Anakinra for Rheumatoid Arthritis: A Systematic Review
- (2009) M. MERTENS et al. JOURNAL OF RHEUMATOLOGY
- An Autoinflammatory Disease with Deficiency of the Interleukin-1–Receptor Antagonist
- (2009) Ivona Aksentijevich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
- (2009) Helen J. Lachmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Autoinflammatory Disease Due to Homozygous Deletion of theIL1RNLocus
- (2009) Sreelatha Reddy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Febrile Seizures: Interleukin 1β and Interleukin-1 Receptor Antagonist Polymorphisms
- (2009) Gul Serdaroğlu et al. PEDIATRIC NEUROLOGY
- Jessner–Kanof disease induced by leflunomide: a dermal variant of cutaneous lupus?
- (2009) Laëtitia Sparsa et al. RHEUMATOLOGY INTERNATIONAL
- Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome
- (2008) A Delluc et al. ANNALS OF THE RHEUMATIC DISEASES
- Successful treatment of resistant pseudogout with anakinra
- (2008) Dennis McGonagle et al. ARTHRITIS AND RHEUMATISM
- The pattern of response to anti–interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis
- (2008) Marco Gattorno et al. ARTHRITIS AND RHEUMATISM
- Persistent efficacy of anakinra in patients with tumor necrosis factor receptor–associated periodic syndrome
- (2008) M. Gattorno et al. ARTHRITIS AND RHEUMATISM
- Inhibition of Interleukin-1 by Anakinra Improves Vascular and Left Ventricular Function in Patients With Rheumatoid Arthritis
- (2008) Ignatios Ikonomidis et al. CIRCULATION
- Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study
- (2008) Norman Ilowite et al. CLINICAL RHEUMATOLOGY
- IL-1 blockade in Schnitzler syndrome: Ex vivo findings correlate with clinical remission
- (2008) John G. Ryan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
- (2008) Veit Hornung et al. NATURE IMMUNOLOGY
- Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation
- (2008) C. Moser et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Antagonism of peripheral inflammation reduces the severity of status epilepticus
- (2008) Nicola Marchi et al. NEUROBIOLOGY OF DISEASE
- Good response to IL‐1β blockade by anakinra in a 23‐year‐old CINCA/NOMID patient without mutations in theCIAS1gene. Cytokine profiles and functional studies
- (2008) C. M. Hedrich et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- A case of macrophage activation syndrome successfully treated with anakinra
- (2008) Alison Kelly et al. Nature clinical practice. Rheumatology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More